MARKER THERAPEUTICS, INC. (MRKR)

Every figure this model derived for MRKR, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-03-31.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
capex 0 PaymentsToAcquirePropertyPlantAndEquipment 2020-03-31
cash 11,331,023 CashAndCashEquivalentsAtCarryingValue 2026-06-30
current assets 14,585,485 AssetsCurrent 2026-06-30
current liabilities 2,420,021 LiabilitiesCurrent 2026-06-30
equity 12,165,464 StockholdersEquity 2026-06-30
ocf -9,756,497 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 3,949,257 RevenueFromContractWithCustomerIncludingAssessedTax 2026-03-31
sbc 518,567 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up MRKR on one particular measure came for.

RatioValue
cash operating margin-258.15
current ratio10.09
current ratio reported6.03
dilution pct70.55
fcf margin-247.05
growth cv5.39
operating margin-271.28
owner earnings margin-260.18
revenue growth-30.67
revenue growth per share-59.35
roic-1014.3
rule of 40-301.95
sbc pct revenue13.13

What to be careful about

What this model itself distrusts about MRKR's figures. Written by the derivation as it ran, not added afterwards.